What the Research Says
Taweerutchana et al. randomized 32 treatment-naïve adults with type 2 diabetes to 8 g/day moringa leaf capsules or placebo for four weeks. No significant fasting-glucose or HbA1c difference was found. The previously stated 4 g, 40-day, 28% reduction does not describe this trial. [4]
Crișan et al. (2025) reviewed nine randomized trials with 649 participants. Moringa had no significant effect on most cardiometabolic outcomes. The small diastolic-pressure result was not robust in sensitivity analyses, and all outcomes were rated very low certainty because of bias, heterogeneity, and other limitations. [6]
Animal and cell research can suggest mechanisms but cannot establish clinical benefit. Poultry feeding studies and rodent ulcer models should not be presented as evidence that human supplements lower glucose, cholesterol, or inflammation. Human treatment regimens and long-term safety remain insufficiently established. [5]




